What is the share price of Nexus Surgical and Medicare Ltd (NEXUSSURGL) today?
The share price of NEXUSSURGL as on 5th June 2025 is ₹17.17. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Nexus Surgical and Medicare Ltd (NEXUSSURGL) share?
The past returns of Nexus Surgical and Medicare Ltd (NEXUSSURGL) share are- Past 1 week: -8.02%
- Past 1 month: 22.38%
- Past 3 months: 16.62%
- Past 6 months: -29.15%
- Past 1 year: 3.98%
- Past 3 years: 48.03%
- Past 5 years: 79.79%
What are the peers or stocks similar to Nexus Surgical and Medicare Ltd (NEXUSSURGL)?
The peers or stocks similar to Nexus Surgical and Medicare Ltd (NEXUSSURGL) include:What is the market cap of Nexus Surgical and Medicare Ltd (NEXUSSURGL) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Nexus Surgical and Medicare Ltd (NEXUSSURGL) is ₹9.68 Cr as of 5th June 2025.What is the 52 week high and low of Nexus Surgical and Medicare Ltd (NEXUSSURGL) share?
The 52-week high of Nexus Surgical and Medicare Ltd (NEXUSSURGL) is ₹29.28 and the 52-week low is ₹12.91.What is the PE and PB ratio of Nexus Surgical and Medicare Ltd (NEXUSSURGL) stock?
The P/E (price-to-earnings) ratio of Nexus Surgical and Medicare Ltd (NEXUSSURGL) is 19.36. The P/B (price-to-book) ratio is 17.29.Which sector does Nexus Surgical and Medicare Ltd (NEXUSSURGL) belong to?
Nexus Surgical and Medicare Ltd (NEXUSSURGL) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Nexus Surgical and Medicare Ltd (NEXUSSURGL) shares?
You can directly buy Nexus Surgical and Medicare Ltd (NEXUSSURGL) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Nexus Surgical and Medicare Ltd
NEXUSSURGL Share Price
17.172.77% (-0.49)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
How to use scorecard? Learn more
NEXUSSURGL Performance & Key Metrics
NEXUSSURGL Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 19.76 | 17.29 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 35.31 | 6.50 | 0.81% |
NEXUSSURGL Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
NEXUSSURGL Company Profile
Nexus Surgical and Medicare Limited is an India-based company engaged in the trading of surgical and pharmaceutical products. It imports and markets a range of medical supplies, including disposable syringes and sterilization pouches.
SUNPHARMA
PE Ratio
36.62
36.62
1Y Return
13.16%
13.16%
Buy Reco %
87.88
87.88
CIPLA
PE Ratio
22.59
22.59
1Y Return
1.67%
1.67%
Buy Reco %
74.19
74.19
TORNTPHARM
PE Ratio
55.67
55.67
1Y Return
12.99%
12.99%
Buy Reco %
72.00
72.00
DRREDDY
PE Ratio
18.46
18.46
1Y Return
7.47%
7.47%
Buy Reco %
56.67
56.67
MANKIND
PE Ratio
48.72
48.72
1Y Return
9.44%
9.44%
Buy Reco %
81.25
81.25
NEXUSSURGL Forecast
NEXUSSURGL Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
NEXUSSURGL
NEXUSSURGL
Income
Balance Sheet
Cash Flow
Annual Normal View
NEXUSSURGL Income Statement
NEXUSSURGL Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.30 | 1.04 | 2.22 | 1.73 | 3.75 | 2.42 | 1.56 | 3.50 | 5.73 | 5.72 | ||||||||||
Raw Materials | 0.37 | 0.89 | 2.09 | 0.78 | 1.02 | 0.43 | 0.10 | 0.93 | 5.06 | 5.06 | ||||||||||
| Power & Fuel Cost | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||
| Employee Cost | 0.08 | 0.22 | 0.09 | 0.15 | 0.32 | 0.22 | 0.25 | 0.24 | ||||||||||||
| Selling & Administrative Expenses | 0.11 | 0.11 | 0.08 | 0.69 | 2.24 | 1.77 | 0.60 | 2.08 | ||||||||||||
| Operating & Other expenses | -0.07 | 0.13 | 0.05 | 5.39 | -0.01 | -0.39 | 0.38 | -0.04 | ||||||||||||
EBITDA | -0.19 | -0.32 | -0.09 | -5.28 | 0.18 | 0.39 | 0.23 | 0.29 | 0.67 | 0.66 | ||||||||||
| Depreciation/Amortization | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||||||
| PBIT | -0.19 | -0.32 | -0.09 | -5.28 | 0.18 | 0.39 | 0.23 | 0.29 | 0.67 | 0.66 | ||||||||||
| Interest & Other Items | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | — | ||||||||||
| PBT | -0.20 | -0.32 | -0.09 | -5.28 | 0.18 | 0.39 | 0.23 | 0.28 | 0.67 | 0.66 | ||||||||||
| Taxes & Other Items | 0.00 | 0.01 | 0.00 | 0.02 | 0.01 | 0.10 | 0.06 | 0.08 | 0.17 | 0.17 | ||||||||||
| Net Income | -0.20 | -0.33 | -0.09 | -5.30 | 0.17 | 0.29 | 0.17 | 0.20 | 0.50 | 0.49 | ||||||||||
| EPS | -0.37 | -0.60 | -0.16 | -9.69 | 0.31 | 0.53 | 0.31 | 0.37 | 0.91 | 0.90 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
NEXUSSURGL Company Updates
NEXUSSURGL Stock Peers
NEXUSSURGL Past Performance & Peer Comparison
NEXUSSURGL Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Nexus Surgical and Medicare Ltd | 19.36 | 17.29 | — |
| Sun Pharmaceutical Industries Ltd | 36.62 | 5.96 | 0.96% |
| Cipla Ltd | 22.59 | 4.44 | 1.08% |
| Torrent Pharmaceuticals Ltd | 55.67 | 15.52 | 1.02% |
NEXUSSURGL Stock Price Comparison
Compare NEXUSSURGL with any stock or ETFCompare NEXUSSURGL with any stock or ETF
NEXUSSURGL
NEXUSSURGL Holdings
NEXUSSURGL Shareholdings
NEXUSSURGL Promoter Holdings Trend
NEXUSSURGL Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
NEXUSSURGL Institutional Holdings Trend
NEXUSSURGL Institutional Holdings Trend
Increased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has increased by 1.37%
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
NEXUSSURGL Shareholding Pattern
NEXUSSURGL Shareholding Pattern
NEXUSSURGL Shareholding History
NEXUSSURGL Shareholding History
Foreign Institutions
smallcases containing NEXUSSURGL stock
smallcases containing NEXUSSURGL stock
Looks like this stock is not in any smallcase yet.
NEXUSSURGL Events
NEXUSSURGL Events
NEXUSSURGL Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
NEXUSSURGL has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
NEXUSSURGL Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
NEXUSSURGL has not given any dividends in last 5 years
NEXUSSURGL Dividends
NEXUSSURGL Dividends
Hmm, looks like data is unavailable here. Please come back after some timeNEXUSSURGL Stock News & Opinions
NEXUSSURGL Stock News & Opinions
Articles & Videos
Earnings
Nexus Surgical and Medicare standalone net profit rises 50.00% in the March 2025 quarter
Net profit of Nexus Surgical and Medicare rose 50.00% to Rs 0.09 crore in the quarter ended March 2025 as against Rs 0.06 crore during the previous quarter ended March 2024. Sales rose 146.67% to Rs 1.48 crore in the quarter ended March 2025 as against Rs 0.60 crore during the previous quarter ended March 2024. For the full year,net profit rose 138.10% to Rs 0.50 crore in the year ended March 2025 as against Rs 0.21 crore during the previous year ended March 2024. Sales rose 64.84% to Rs 5.72 crore in the year ended March 2025 as against Rs 3.47 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales1.480.60 147 5.723.47 65 OPM %7.4313.33 -11.547.49 - PBDT0.120.08 50 0.670.29 131 PBT0.120.08 50 0.670.29 131 NP0.090.06 50 0.500.21 138 Powered by Capital Market - Live
5 days agoCapital Market - Live
Corporate
Nexus Surgical & Medicare to discuss results
Nexus Surgical & Medicare will hold a meeting of the Board of Directors of the Company on 30 May 2025.Powered by Capital Market - Live
1 week agoCapital Market - Live
Earnings
Nexus Surgical and Medicare standalone net profit rises 120.00% in the December 2024 quarter
Net profit of Nexus Surgical and Medicare rose 120.00% to Rs 0.11 crore in the quarter ended December 2024 as against Rs 0.05 crore during the previous quarter ended December 2023. Sales rose 2.07% to Rs 1.48 crore in the quarter ended December 2024 as against Rs 1.45 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales1.481.45 2 OPM %10.144.14 - PBDT0.150.07 114 PBT0.150.07 114 NP0.110.05 120 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Nexus Surgical & Medicare to conduct board meeting
Nexus Surgical & Medicare will hold a meeting of the Board of Directors of the Company on 21 January 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Earnings
Nexus Surgical and Medicare standalone net profit rises 162.50% in the September 2024 quarter
Net profit of Nexus Surgical and Medicare rose 162.50% to Rs 0.21 crore in the quarter ended September 2024 as against Rs 0.08 crore during the previous quarter ended September 2023. Sales rose 167.57% to Rs 0.99 crore in the quarter ended September 2024 as against Rs 0.37 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales0.990.37 168 OPM %28.2824.32 - PBDT0.280.11 155 PBT0.280.11 155 NP0.210.08 163 Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Nexus Surgical & Medicare to conduct board meeting
Nexus Surgical & Medicare will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live
6 months agoCapital Market - Live
Earnings
Nexus Surgical and Medicare standalone net profit rises 200.00% in the June 2024 quarter
Net profit of Nexus Surgical and Medicare rose 200.00% to Rs 0.09 crore in the quarter ended June 2024 as against Rs 0.03 crore during the previous quarter ended June 2023. Sales rose 66.04% to Rs 1.76 crore in the quarter ended June 2024 as against Rs 1.06 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales1.761.06 66 OPM %6.822.83 - PBDT0.120.04 200 PBT0.120.04 200 NP0.090.03 200 Powered by Capital Market - Live
9 months agoCapital Market - Live
Corporate
Nexus Surgical & Medicare to announce Quarterly Result
Nexus Surgical & Medicare will hold a meeting of the Board of Directors of the Company on 13 August 2024.Powered by Capital Market - Live
9 months agoCapital Market - Live
Corporate
Nexus Surgical & Medicare schedules AGM
Nexus Surgical & Medicare announced that the 33th Annual General Meeting (AGM) of the company will be held on 23 August 2024.Powered by Capital Market - Live
10 months agoCapital Market - Live
Corporate
Nexus Surgical & Medicare to declare Quarterly Result
Nexus Surgical & Medicare will hold a meeting of the Board of Directors of the Company on 25 July 2024.Powered by Capital Market - Live
10 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 9.53%, vs industry avg of 9.01%
Over the last 5 years, market share stayed at 0%